Live feed
Filing
SC 13G/A
SC 13G/A0000902219-20-000394·AERIE PHARMACEUTICALS INC
Schedule 13G ownership disclosure
AERIE PHARMACEUTICALS INC
Security class unavailable · CUSIP: 00771V108
Event date: 2020-05-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,291,200
- Percent of class
- 9.2300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-20-000394
- Form type
- SC 13G/A
- Filer
- AERIE PHARMACEUTICALS INC
- CIK
- CIK 1337553
- Filed
- Jun 09, 2020
- Reporting period
- May 29, 2020
- Description
- Schedule 13G beneficial ownership